91.1% of individual equity futures-and-options traders lost money after transaction costs in FY24, according to SEBI's study of individual derivatives traders. That's a strong reason to build an investing process around businesses, not frequent trading opportunities. It doesn't prove that long-term stock picking guarantees profits. It shows why speculation deserves a different toolkit from investing.
For Indian smallcap and midcap investors, the useful questions are straightforward. Does the company generate cash? Can it grow without stretching its balance sheet? Are you paying a sensible price, and could you exit if the business deteriorates?
The best stock screener for long term investment should help answer those questions before you commit money. For a five-year-plus workflow, I rank fundamentals depth, valuation tools, historical testing and smaller-company research above trading scans.
- Choose Investor Tools for a valuation-led investing toolkit.
- Start with Screener.in for focused DIY fundamental research.
- Choose Trendlyne when historical rewind and backtesting are essential.
These seven picks serve different jobs. Buy the research capability you'll use, not the longest feature list.
Table of Contents
- 1. Investor Tools
- 2. Screener.in
- 3. Tickertape
- 4. Tijori Finance
- 5. Trendlyne
- 6. StockEdge
- 7. Chartink
- Best Stock Screeners for Long-Term Investing: 7-Tool Comparison
- Pick Your Screener and Start Compounding
1. Investor Tools
Investors who want valuation checks alongside portfolio tracking can look at Futurecaps Investor Tools, which bundles several utilities in one place. These include an intrinsic value calculator, portfolio tracker, stock screener, alert tools, the Fiwiser financial-wisdom platform and a Rent vs Buy Calculator. For a five-year-plus Indian stock workflow, the relevant question is whether its valuation and monitoring features add value beyond a dedicated screener.
Use valuation as the gatekeeper
Start with the business, then use a valuation calculator to test your assumptions. A calculator is a weighing scale, not proof that a stock is cheap. Keep your investment thesis separate from the tool's output, and check annual reports and exchange filings before acting.
The India stock screener guide can help you set up a screening process. The value of a bundled toolkit depends on whether you will use its valuation and alert features regularly. It is most useful for investors who already know which valuation inputs they trust.
- Main advantage: Screening, valuation, portfolio tracking and alerts are grouped in one offering.
- Best fit: Investors who want a structured process for researching and monitoring Indian companies.
- Access limitation: Check which tools are free, which require a subscription and what each plan includes.
- Research limitation: Confirm whether historical rewind and point-in-time backtesting are available before relying on them.
Choose this toolkit for valuation checks and portfolio monitoring, then compare its screening depth with focused research platforms. Calculators and alerts can support decisions, but they cannot replace independent analysis or prevent losses.
2. Screener.in
If you already read annual reports and want to test a query before opening them, Screener.in offers a direct place to start. Build a reusable screen for growth, profitability, debt, valuation and market capitalisation, then investigate the companies that pass. Its strength is fundamental research for long-holding investors, not trading scans.
Screener.in offers a free Hobby Investor plan and an Active Investor Premium plan listed at ₹4,999 annually, inclusive of GST. Company financial statements, historical charts, peer comparisons, segment results and alerts support deeper research. Excel automation is available on free and paid plans, while Premium expands features and limits.
Build rules you understand
Query-based screening gives you control, but only if you understand the measures you combine. The guide to best metrics for stock selection can help you distinguish genuine profitability from a flattering headline ratio. Compare earnings with operating cash flow, and check whether debt changes the investment case.
A saved screen should preserve your discipline, not preserve a mistake. Review the formula as carefully as the companies it returns.
Upgrade only when a stated limit blocks a specific task, such as saving more screens or downloading more data than the free plan permits. Check the current limits on the pricing page before paying. For desktop-led fundamental research, start free and identify the constraint first.
Before installing the mobile app, compare the developer name on its Google Play listing with the name shown on Screener.in's official help page. Install it only if the names match. Historical financial charts help you examine past performance, but they are not a point-in-time strategy backtest.
3. Tickertape
Open Tickertape, pick the quality theme, and count how many companies remain after you add a single debt filter. That short exercise shows you what each condition does, which makes the visual interface a strong fit for long-term investors who find a blank query box intimidating.
Tickertape's equity screener provides free access, while Pro is listed at ₹399 monthly, ₹899 for three months or ₹2,999 annually. Features include profitability, growth, valuation, ownership and financial-statement filters, custom filters, saved screens and CSV export. Pro adds further filters, forecasts and portfolio capabilities.
- Best feature: Visual filtering makes it easier to see which condition excludes a company.
- Practical advantage: Saved custom screens let you move beyond someone else's preset.
- Main drawback: Some filters require Pro, and its broader capabilities may exceed a basic screener user's needs.
Graduate from presets to judgement
A wealth-compounder label isn't evidence of future compounding. The label rests on a preset bundle of conditions, so open the theme, note which filters it applies, and compare the company's five-year revenue and operating profit growth with those thresholds before you accept it. Then use the hidden-compounder screening framework to investigate growth durability, cash generation and valuation.
For smaller companies, open the underlying financial statements rather than accepting a clean-looking filter result. Check whether growth comes from the operating business or exceptional gains, and whether the relevant figures are consolidated or standalone.
Beginners who want guided filters rather than a blank query should start here, then save only the conditions they can explain in one sentence. Don't pay for forecasts or extra portfolio features unless they fix a defined gap in your research process.
4. Tijori Finance
A company can look strong on ratios and still depend on one raw material. Tijori Finance helps you see that dependency before you commit.
The platform combines screening with company financials, shareholding information, market-share data, operating metrics and sector research. Its free plan includes financial statements and public or popular screening queries. Tijori's plans page lists paid access at $4 monthly or $43 annually, so Indian users should confirm billing currency and checkout terms before subscribing.
Understand the source of profits
Run Tijori on a candidate after your screen flags it, then examine how the company earns its money. Revenue mix and operating metrics frame questions a valuation multiple can't answer. Does profitability rest on a favourable raw-material environment, a narrow product category, or conditions that could reverse within your five-year holding period? This matters most for smaller companies, where a single customer or input can carry the entire thesis.
Paid capabilities include historical data, deeper financial comparisons, reverse DCF and source links. Reverse DCF is useful for challenging expectations: examine what the current price requires the company to achieve, rather than selecting assumptions that produce your preferred valuation.
- Why choose it: Business and sector context complements numerical screening.
- Why pause: Some historical and comparative information requires paid access.
- What to verify: Check important metrics against company filings, including their definitions and reporting periods.
Tijori describes itself as a research and analytics platform rather than an advisory or stock-recommendation service. Compare any figure Tijori shows against the company's own annual report before using it in your notes. Use it to improve your understanding of a shortlisted business, not to outsource the buy decision.
5. Trendlyne
Suppose your rule combines a debt ceiling with a valuation limit. Trendlyne lets you test how that screen would have selected stocks at earlier dates, a question a live screen alone cannot answer. For a five-year-plus investor, that historical check can expose rules that only look good in today's market.
Trendlyne offers fundamental and technical filters, DVM scores, expert screeners, portfolio analysis and analyst-consensus forecasts. DVM stands for Durability, Valuation and Momentum. Trendlyne's India plans page lists GuruQ at ₹390 monthly. StratQ is sold annually only, so confirm its current annual price and included features on that page before paying.
Test the process, not a flattering result
Paid-plan features include screener alerts, historical rewind and backtesting. Test your quality-and-value rules across different market conditions. Set the rules first, then assess the results.
Backtesting discipline: Check what information was available on each historical screening date. A result can mislead if it relies on information investors could not have known at the time.
Ask how the test handles reporting delays, corporate actions, delisted companies and transaction assumptions. Treat these as questions to verify, not features to assume from the presence of a backtest.
Trendlyne's breadth comes with a learning curve. New investors can spend more time interpreting scores than examining businesses. Use DVM as one comparison input, alongside cash-flow analysis and governance checks. Write your rules before opening the tool, then reject any filter added only because it improved the historical result. Trendlyne provides analysis tools, not stock recommendations.
6. StockEdge
StockEdge suits investors who prefer starting with predefined scans and then studying the sector. You don't need to build every condition yourself before finding research candidates. The important discipline is to separate fundamental discovery from the platform's broader trading features.
StockEdge offers more than 500 predefined scans across fundamental, technical, price, volume and other categories. It also provides combination scans, sector and industry analysis, fundamental scores and investor-portfolio research. A free tier is available, while Premium is listed at ₹399 monthly and Pro at ₹1,499 monthly; annual pricing and promotional offers may also appear.
- Use predefined scans to generate candidates without starting from a blank query.
- Use combination scans to apply related conditions together.
- Use sector analysis to compare a company with businesses facing similar economic conditions.
Add an exit-liquidity test
For smallcap research, don't stop at growth and return ratios. Stress disclosures discussed in an analysis of smallcap mutual-fund liquidity showed that liquidating half of some portfolios could take 25–57 days. That's a fund-level observation, not a retail exit estimate, but it makes liquidity impossible to dismiss.
For each shortlisted share, inspect traded value, free float, bid–ask spreads and your intended position size. Don't assume a scan has assessed whether you can sell.
StockEdge's main drawback is distraction. Technical and trading features can clutter a fundamentals-only routine, and custom-scan limits vary by subscription. Choose it for discovery and sector context, then perform your own suitability and liquidity assessment.
7. Chartink
Chartink belongs last for this long-term workflow, not because flexibility is unhelpful, but because fundamental research needs more than a flexible scan builder. Choose it when you already know the conditions you want to combine. Don't choose it as your main teacher of business quality.
Chartink offers free custom scanning and a paid plan listed at ₹780 monthly, ₹2,220 quarterly or ₹8,500 annually. Users can combine technical indicators with available fundamental parameters and draw on a public scan library. Paid features include alerts, auto-refresh and other monitoring functions; the subscription information describes price data as sourced from the NSE feed and updated near real time unless otherwise indicated.
Keep the scan subordinate to research
Public scans are examples, not endorsed investment strategies. Before saving one, inspect every condition and remove anything you can't explain. A scan that combines unrelated indicators can look complex while offering little help with a long-term thesis.
Use Chartink to find matches to your rules. Use company filings to decide whether those rules found a business worth owning.
Its advantage is customisation; its weakness is interpretation. Chartink can identify shares meeting your conditions, but that result doesn't explain competitive position, management behaviour or the risk of permanent capital loss.
For fundamentals-first investors, many prominent monitoring features are unnecessary. Keep Chartink as a supplementary discovery tool after establishing your financial-research process elsewhere. If you're still learning how to assess earnings quality and valuation, start with Screener.in or Tickertape instead.
Best Stock Screeners for Long-Term Investing: 7-Tool Comparison
This ranking is built for five-year-plus Indian multibagger workflows: fundamentals depth, valuation filters, backtesting or rewind, and smallcap coverage. Trading scans do not earn extra marks here.
| Tool | 🔄 Setup / Complexity | ⚡ Cost / Resources | 📊 Expected Outcome | 💡 Ideal Use Case | ⭐ Key Advantage |
|---|---|---|---|---|---|
| Investor Tools | Low to moderate; several tools in one offering | Pricing and access terms not specified | Supports valuation, portfolio organisation, screening, and alerts | Indian investors seeking a structured, long-term research workflow | Combines practical investing utilities with research and education |
| Screener.in | Moderate; query-based screens take practice | Free plan; Premium listed at ₹4,999/year (pricing) | Reusable screens and detailed company financial research | DIY fundamental investors building criteria-based screens | Strong financial data focus and free entry-level access |
| Tickertape | Low to moderate; guided filters and ready-made screens | Free plan; Pro listed from ₹399/month (pricing) | Helps discover stocks and review company or portfolio data | Beginners and investors who prefer a visual interface | Custom filters combined with pre-built screens |
| Tijori Finance | Moderate; research features benefit from financial context | Free plan; paid access listed at $4/month or $43/year (pricing) | Adds company and sector context to screening | Investors researching business drivers and industry trends | Operating metrics and sector research complement financial ratios |
| Trendlyne | High; extensive screening and analytics toolkit | GuruQ listed at ₹390/month; StratQ annual pricing varies (pricing) | Enables detailed screens, alerts, and historical testing | Experienced investors with defined strategies | Broad parameters, DVM scores, alerts, and backtesting |
| StockEdge | Moderate to high; many scans and tools to learn before the first useful result | Free tier; Premium listed at ₹399/month and Pro at ₹1,499/month (pricing) | Generates research shortlists and sector-level comparisons | Investors wanting predefined scans and sector analysis | Large scan library spanning fundamental and technical data |
| Chartink | High; useful scans require rule-building and interpretation | Free plan; paid plan adds alerts, auto-refresh and monitoring | Finds stocks matching custom technical or fundamental conditions | Users who know their screening rules and want flexible scans | Customisable scan combinations and a library of public scans |
Scan count matters less than whether the tool lets you test an idea against history, check a valuation properly, and research a small company before you commit capital.
Pick Your Screener and Start Compounding
Shortlist two screeners, run one combined value-and-quality filter, then track the results for five years. That's a research commitment, not an instruction to buy every result or hold a deteriorating business blindly. Save the original shortlist, screening date, assumptions and rejection reasons so you can judge your process fairly.
My preferred pairing is Investor Tools for valuation and portfolio discipline, plus Screener.in for DIY financial research. Choose Trendlyne instead when historical rewind and backtesting are central to your method. Add Tijori when understanding the business and sector requires more work.
Put rejection rules before return targets
Start with durable sales and earnings, cash generation, manageable debt, sensible return ratios and a valuation you can defend. Then investigate promoter pledges, weak cash conversion, customer concentration, dilution and governance concerns. For smaller companies, include free float and exit feasibility before deciding position size.
- Check data consistency: Compare consolidated with consolidated figures, and identify whether ratios use annual or trailing-period earnings.
- Challenge the valuation: Examine what happens if growth slows, margins weaken or the expected valuation multiple falls.
- Protect household goals: Keep money needed for essential near-term spending outside a speculative stock-selection exercise.
Capital preservation deserves that emphasis. SEBI's Investor Survey found that nearly 80% of households preferred capital preservation over higher returns. A screen producing fewer understandable candidates can serve you better than a crowded list of supposed multibaggers.
Before paying for researched ideas, verify the provider's regulatory status. SEBI's Research Analyst investor charter advises investors to deal only with registered analysts and verify that their registration certificate is valid.
The best screener is the one you'll use consistently and question intelligently. Build the shortlist, verify the filings and buy only when business quality, valuation and portfolio suitability agree.
Futurecaps Stocks offers India-focused, SEBI-registered equity research, investor education and tools for assessing long-term midcap, smallcap and microcap opportunities. Visit Futurecaps Stocks to connect your screening process with researched investment theses, valuations and risk factors. When you're ready to examine a free stock idea, select the Free Multibagger button and apply the same quality-and-value checks before investing.
